SLRN
ACELYRIN, INC. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$229.17M
P/E Ratio
—
EPS
$-2.69
Beta
1.09
52W High
$2.65
52W Low
$1.95
50-Day MA
$2.40
200-Day MA
$3.55
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About ACELYRIN, INC. Common Stock
Acelyrin, Inc., a clinical biopharma company, focuses on identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company is headquartered in Agoura Hills, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-270.06M |
| Operating Margin | 0.00% |
| Return on Equity | -51.10% |
| Return on Assets | -29.80% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $4.04 |
| Price-to-Book | 0.56 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 0.46 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $100.95M |
| Float | $68.45M |
| % Insiders | 7.15% |
| % Institutions | 91.98% |
Historical Volatility
HV 10-Day
0.00%
HV 20-Day
0.00%
HV 30-Day
0.00%
HV 60-Day
49.56%
HV Rank
—
Volatility is currently contracting
Data last updated: 4/15/2026